News | November 21, 2025
EMA launches streamlined process to fast-track critical medicines, vaccines
The move is expected to be crucial during health crises
The move is expected to be crucial during health crises
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Venus Remedies now has 29 active product approvals in Vietnam alone
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Marks first international filing for Evofem’s single-dose oral treatment
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
This milestone marks the first-ever NDA submission to the U.S. FDA for a drug, fully discovered and developed by an Indian pharmaceutical company
Subscribe To Our Newsletter & Stay Updated
